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Molecular chaperones: Pathways and networks
R. John Ellis
Some proteins synthesized by growing eukaryotic cells
are transferred along unidirectional pathways of
molecular chaperones until the risk of aggregation has
decreased and they can be released safely. Mature
proteins denatured by stress may instead be handled by
chaperones acting in branched, reversible networks.
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Over twenty families of protein meet the suggested criteria
for acting as molecular chaperones: they assist the non-
covalent assembly and/or disassembly of protein-contain-
ing structures in vivo, but are not permanent components
of these structures when the latter are performing their
normal biological functions [1]. Members of at least seven
of these families are also known to be stress proteins –
they increase in amount when the organism experiences
abnormal conditions, such as elevated temperatures. The
chaperone functions of these stress, or heat-shock, pro-
teins depend upon their ability to recognise and bind to
hydrophobic regions of proteins that become exposed to
the intracellular milieu, either during the synthesis and
folding of protein chains under normal growth conditions
or after the denaturation of mature proteins caused by
environmental stresses. This binding is non-covalent and
reversible, and serves to reduce the chance that such
exposed regions will aggregate with one another or trigger
premature proteolytic degradation [2]. 
Recent work with growing yeast [3,4] and Chinese
hamster ovary (CHO) cells [5] suggests that chaperones
binding to newly synthesized protein chains direct these
chains efficiently along a linear pathway that acts as a
folding compartment, and do not permit their release into
the intracellular media (the cytosol and the mitochondrial
matrix) in partially folded states until the danger of aggre-
gation of such states has receded (Figure 1a). This ‘chap-
erone pathway’ view contrasts with a ‘network’ model
(Figure 1b), based on in vitro reconstitution experiments
[6] and in vivo observations with non-growing Xenopus
oocytes [7], in which partially folded proteins are released
into the soluble cytosolic medium to compete for binding
to different chaperones. The network model may be more
applicable to the refolding of stress-denatured proteins
than to the folding of newly synthesized proteins in cells
growing under normal conditions [6].
Networks versus pathways
The idea that partially folded and aggregation-prone pro-
teins may normally be released into the soluble intracellular
medium runs counter to the conclusion from prokaryotic
genetic experiments, which showed that one of the major
functions both of the cage-like GroEL chaperonin and of
DnaK, the Escherichia coli homologue of the eukaryotic
heat-shock protein Hsp70, is to prevent the aggregation of
such proteins [2]. Nevertheless, release of partially folded
chains from GroEL into the bulk medium, followed by
rebinding to other GroEL molecules, has been demon-
strated with reconstituted systems in vitro and this has led
to the iterative annealing model for GroEL action [8]. In
this model, the role of GroEL is to partly unfold misfolded
proteins and then release them into the bulk medium to
allow them another chance to fold correctly in that medium.
In vitro work from other laboratories supports an alternative
sequestration model, in which partially folded chains are
retained individually inside the central cage of the GroEL
chaperonin by a cap of GroES protein; they then continue
to fold, and are released from the cage only when the
danger of aggregation with similar chains has passed [2,9].
These two models are not mutually exclusive, given that
both describe what has been observed under a given set of
conditions in vitro, and it is at least conceivable that each
model has evolved to operate with its own distinct spec-
trum of protein substrates that differ in their susceptibility
to aggregation. The issue is whether the sequestration
model predominates in vivo, as some suggest [2], or
whether, in addition, partially folded proteins cycle
between GroEL and DnaK in the soluble intracellular
medium [9]. The partially folded states of some proteins
are not prone to aggregation and are not recognised by
chaperones; this debate thus concerns only the 10–20% of
newly synthesized proteins that bind to the GroEL and
TRiC (TCP-1-containing ring complex) chaperonins, in
E. coli and certain mammalian cells, respectively [10].
Until the recent work [3–5], the strongest argument that
the sequestration model is likely to predominate for newly
synthesized proteins in vivo was a theoretical one, based on
the prediction that the physical phenomenon of macromol-
ecular crowding operating inside cells would greatly
enhance the probability of aggregation of partially folded
proteins [2,11]. Aggregation is commonly observed during
the refolding of some denatured proteins, even though the
buffers used are uncrowded compared to intracellular
media. If aggregation is an even more serious problem
inside the cell than it is in vitro, it seems likely that differ-
ent chaperones acting at various points during the synthesis
of protein chains will transfer the chains efficiently
between them along a defined sequential pathway, rather
than release them into a soluble pool. But it has been
shown recently that denatured firefly luciferase can fold
correctly while shuffling back and forth between the DnaK
and GroEL chaperones in a pure reconstituted in vitro
system [6], leading the authors to suggest that chaperone-
mediated protein folding in the cell is not necessarily unidi-
rectional, but instead may constitute a lateral network of
co-operating chaperones. Thus, the debate turns on how far
conclusions based on observations made using various in
vitro systems reflect what happens in the intact cell.
Such disputes cannot be resolved by yet more observa-
tions on standard protein refolding systems: they require
the use either of in vitro systems that reflect intracellular
conditions more closely than pure chaperones mixed in
uncrowded buffers or of relevant in vivo systems. Strong
evidence favouring the chaperone pathway model for
newly synthesized cytosolic proteins has now been pro-
vided by the use of mutant GroEL molecules expressed
inside both yeast [3] and CHO cells [5], and from studies
of the folding of newly synthesized luciferase imported
into yeast mitochondria, both in vivo and ‘in organello’ [4].
Evidence for the pathway model inside mitochondria
Luciferase is made in nature by the cytosolic ribosomes of
the firefly, and it is then transported into peroxisomes.
When fused with a mitochondrial targeting signal and
expressed from a plasmid in the cytosol of yeast cells,
luciferase chains appear inside the mitochondria, where
they first bind to Hsp70 (the mitochondrial DnaK homo-
logue) and then to mitochondrial GroEL [3]. About 90% of
these chains remain bound to GroEL in an enzymically
inactive state, and only about 10% appear in the mitochon-
drial matrix where their enzymic activity can be measured.
Thus, although luciferase bound to GroEL in vitro can be
released into the medium to fold correctly, provided DnaK
is also present to prevent aggregation [6], this is not the case
for luciferase imported into yeast mitochondria, where the
chaperone pathway operates in a unidirectional manner [3].
What determines unidirectionality in this case is not clear,
but it may reflect the increase in association between partly
folded luciferase and GroEL that is predicted to result from
the crowded state of the mitochondrial matrix. This inter-
pretation is supported by the report that the addition of the
synthetic crowding agents Ficoll and dextran to a refolding
system containing GroEL and rhodanese inhibits the
release of partially folded rhodanese chains from GroEL
into the medium [12]. Thus, while iterative annealing is a
feature of some in vitro refolding systems, it may not apply
to proteins newly synthesized in vivo.
A criticism of all experiments involving firefly luciferase
and GroEL is that luciferase is neither a natural substrate
for GroEL nor capable of being released into its central
cage to allow correct folding, probably because of its size
(62 kDa). Nevertheless, the different behaviour of
luciferase in these two reports cautions against extrapolat-
ing to the in vivo situation observations made with recon-
stituted in vitro systems.
Evidence for the pathway model in eukaryotic cytosol
If partially folded proteins capable of being recognised by
GroEL are released into the cytosol shortly after their syn-
thesis, it should be possible to detect them by utilising the
properties of a mutant form of GroEL called ‘trap GroEL’.
This GroEL mutant, D87K, is defective in ATP hydroly-
sis, and as a result it binds to partially folded proteins with
the same affinity as wild-type GroEL but is unable to
release them, whether ATP is present or not; it acts as a
trap for partially folded chains [7]. Trapping of such chains
would be expected to inhibit cell growth since it would
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Figure 1
Comparison of the pathway (a) and network (b) models for the
chaperone-assisted folding of newly synthesized proteins. The red line
represents a polypeptide chain, while ‘small chaperones 1 and 2’
represent chaperones of the DnaK/DnaJ type [2,10]. The term
‘unfolded’ refers to the ensemble of partially folded states that free
chains may adopt before reaching their final conformations. The
critical distinction between the two models is the extent to which
unfolded states are released into the intracellular medium while they



















prevent the subsequent completion of their folding.
Expression of trap GroEL in the cytosol of either yeast [4]
or CHO cells [5] does not inhibit their growth, nor does it
result in the trapping of the vast majority (> 99%) of newly
synthesized protein chains labelled with 35S-methionine
or a reduction in the rate of folding of newly synthesized
actin. But do these negative effects of trap GroEL mean
that partially folded proteins are not released into the
cytosol, or does it result from a failure of the trap GroEL
to bind to such proteins under intracellular conditions?
Evidence that trap GroEL is functional in vivo
Trap GroEL could fail to function for several possible
reasons. It could be expressed at too low a level to
compete effectively with the endogenous chaperonin TriC
in the eukaryotic cytosol, it could become saturated with
pre-existing unlabelled proteins before the 35S-methionine
is applied, it could release bound proteins during the
extraction procedures, or it could simply be inactivated by
some unknown process. Evidence is available to rule out
each of these explanations.
From earlier experiments in vitro, GroEL is known to
have a higher affinity for partially folded actin than does
TriC, while the level of expression in yeast cells is such
that the trap GroEL is present in the cytosol at ten times
the concentration of TriC [3]. Moreover, the trap GroEL
present in extracts of yeast cells is capable of binding par-
tially folded actin in a quantitative manner, indicating that
it is fully active in these extracts. A positive demonstra-
tion that trap GroEL is active in vivo is provided for both
yeast and CHO cells. Thus, actin synthesized inside yeast
cells in a form incapable of correct folding due to a muta-
tion in TRiC is found in cell extracts bound to trap
GroEL [4], while treatment of CHO cells with either a
proline analogue or heat stress generates misfolded pro-
teins that similarly can be detected bound to extracted
trap GroEL [5].
These observations strongly support the chaperone
pathway model for proteins newly synthesized by growing
yeast and CHO cells; but the mechanisms that ensure the
high integrity of this folding compartment in these cells
remain to be determined. By contrast, injection of trap
GroEL into the cytoplasm of non-growing Xenopus oocytes
inhibits the folding of newly synthesized actin; technical
limitations prevented the isolation from these oocytes of
trap GroEL bound to actin [7], so the mechanism of this
inhibition is unclear. Future work should test the possibil-
ity that the efficiency with which the chaperone pathway
transfers partially folded proteins between its members
varies with cell type and with the cell’s metabolic activity.
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